Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Sebastian Hempel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4268-9902; OpenAlex author ID A5047274323. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 10

  1. Health-related quality of life among patients with colorectal und pancreatic cancer: results from a monocentric registry study. Co-author DOI 10.1055/a-2776-2703↗
  2. Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pancreatic Cancer Surgery. Co-author DOI 10.1245/s10434-026-19628-8↗
  3. ASO Visual Abstract: Combined Preoperative Risk Score Including sCD40, Leukocytes, and BMI Predicts Pancreas-Specific Complications After Pancreatic Cancer Sur… Co-author DOI 10.1245/s10434-026-19708-9↗
  4. The Value of Blood T Cell Frequencies for Risk Prediction of Postoperative Complications in Pancreatic Cancer Surgery. Co-author DOI 10.1097/as9.0000000000000545↗
  5. Predicting resectability after neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer: a single center, retrospective trial. First author DOI 10.3389/fonc.2025.1602933↗
  6. Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvβ6-integrin PET/CT using 68Ga-Trivehexin: incidental detection of a brain metas… Co-author DOI 10.1007/s00259-024-06750-6↗
  7. αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin. Co-author DOI 10.3389/fnume.2024.1487602↗
  8. RAB27B expression in pancreatic cancer is predictive of poor survival but good response to chemotherapy. Co-author DOI 10.3233/cbm-220460↗
  9. Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection. Co-author DOI 10.1038/s41598-017-08165-w↗
  10. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection. First author DOI 10.1245/s10434-016-5515-6↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marius Distler · 8 shared papers, 2016–2026 · strength 1.49
  2. Florian Oehme · 6 shared papers, 2023–2026 · strength 1.39
  3. Jürgen Weitz · 7 shared papers, 2016–2026 · strength 1.27
  4. Lena Seifert · 4 shared papers, 2025–2026 · strength 0.95
  5. David Digomann · 3 shared papers, 2025–2026 · strength 0.72
  6. Adrian M. Seifert · 3 shared papers, 2025–2026 · strength 0.72
  7. Loreen Natusch · 3 shared papers, 2025–2026 · strength 0.72
  8. Michael B. Ghadimi · 2 shared papers, 2026 · strength 0.50
  9. Sarah Cronjaeger · 2 shared papers, 2026 · strength 0.50
  10. Jörg Kotzerke · 2 shared papers, 2024 · strength 0.46
  11. Johannes Notni · 2 shared papers, 2024 · strength 0.46
  12. Jana Rehm · 2 shared papers, 2024 · strength 0.46
  13. Daniela Piontek · 1 shared paper, 2026 · strength 0.26
  14. Jochen M. Schmitt · 1 shared paper, 2026 · strength 0.26
  15. Florian Schepp · 1 shared paper, 2025 · strength 0.24
  16. Christian Teske · 1 shared paper, 2025 · strength 0.24
  17. Max Heiduk · 1 shared paper, 2025 · strength 0.22
  18. Franziska Baenke · 1 shared paper, 2023 · strength 0.18
  19. Mathieu Pecqueux · 1 shared paper, 2023 · strength 0.18
  20. Christoph Kahlert · 1 shared paper, 2023 · strength 0.18
  21. Franz Mierke · 2 shared papers, 2016–2017 · strength 0.14
  22. Thilo Welsch · 2 shared papers, 2016–2017 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.